US Stock MarketDetailed Quotes
SNSE Sensei Biotherapeutics
- 0.521
- +0.037+7.67%
Close Nov 22 16:00 ET
- 0.530
- +0.009+1.65%
Post 19:57 ET
13.11MMarket Cap-437P/E (TTM)
0.542High0.472Low431.42KVolume0.472Open0.484Pre Close221.32KTurnover2.61%Turnover RatioLossP/E (Static)25.15MShares1.94052wk High0.29P/B8.62MFloat Cap0.38452wk Low--Dividend TTM16.55MShs Float26.500Historical High--Div YieldTTM14.38%Amplitude0.384Historical Low0.513Avg Price1Lot Size
About Sensei Biotherapeutics Company
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Company Profile
SymbolSNSE
Company NameSensei Biotherapeutics
Listing DateFeb 4, 2021
Issue Price19.00
Founded1999
CEOMr. John Celebi
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address1405 Research Boulevard`,Suite 125
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-8000
Websitehttp://senseibio.com
Company Executives
- Name
- Position
- Salary
- John Celebi
- President, Chief Executive Officer and Director
- 1.01M
- Stephanie Krebs
- Chief Business Officer
- --
- Edward Van der Horst
- Chief Scientific Officer
- 739.08K
- Josiah Craver
- Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- --
- William R. Ringo, Jr
- Chairman of the Board
- 101.57K
- Dr. James Peyer, PhD
- Independent Director
- 68.43K
- Dr. Deneen Vojta, M.D.
- Independent Director
- 69.32K
- Thomas G. Ricks
- Independent Director
- 75.56K
- Kristian F. Humer
- Independent Director
- 62.24K
- Bob Holmen
- Independent Director
- 73.39K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data